Johnson ES - Search Results

1

Secular trends in kidney disease: is the decreased incidence of renal replacement therapy due to a decrease in chronic kidney disease incidence?

Thorp ML, Weinstein JR, Johnson ES, Yang X, Smith DH. Thorp ML, et al. Among authors: johnson es. Clin Nephrol. 2008 Sep;70(3):187-93. doi: 10.5414/cnp70187. Clin Nephrol. 2008. PMID: 18793559

2

Managing the burden of chronic kidney disease.

Thorp ML, Eastman L, Smith DH, Johnson ES. Thorp ML, et al. Among authors: johnson es. Dis Manag. 2006 Apr;9(2):115-21. doi: 10.1089/dis.2006.9.115. Dis Manag. 2006. PMID: 16620197 Review.

3

Effect of ergocalciferol supplementation on serum parathyroid hormone and serum 25-hydroxyvitamin D in chronic kidney disease.

DeVille J, Thorp ML, Tobin L, Gray E, Johnson ES, Smith DH. DeVille J, et al. Among authors: johnson es. Nephrology (Carlton). 2006 Dec;11(6):555-9. doi: 10.1111/j.1440-1797.2006.00698.x. Nephrology (Carlton). 2006. PMID: 17199797 Clinical Trial.

4

Predicting renal replacement therapy and mortality in CKD.

Johnson ES, Thorp ML, Yang X, Charansonney OL, Smith DH. Johnson ES, et al. Am J Kidney Dis. 2007 Oct;50(4):559-65. doi: 10.1053/j.ajkd.2007.07.006. Am J Kidney Dis. 2007. PMID: 17900455

5

Predicting the risk of dialysis and transplant among patients with CKD: a retrospective cohort study.

Johnson ES, Thorp ML, Platt RW, Smith DH. Johnson ES, et al. Am J Kidney Dis. 2008 Oct;52(4):653-60. doi: 10.1053/j.ajkd.2008.04.026. Epub 2008 Jun 30. Am J Kidney Dis. 2008. PMID: 18585833

6

Lower visual acuity predicts worse utility values among patients with type 2 diabetes.

Smith DH, Johnson ES, Russell A, Hazlehurst B, Muraki C, Nichols GA, Oglesby A, Betz-Brown J. Smith DH, et al. Among authors: johnson es. Qual Life Res. 2008 Dec;17(10):1277-84. doi: 10.1007/s11136-008-9399-1. Epub 2008 Oct 30. Qual Life Res. 2008. PMID: 18972222

7

Effect of anaemia on mortality, cardiovascular hospitalizations and end-stage renal disease among patients with chronic kidney disease.

Thorp ML, Johnson ES, Yang X, Petrik AF, Platt R, Smith DH. Thorp ML, et al. Among authors: johnson es. Nephrology (Carlton). 2009 Apr;14(2):240-6. doi: 10.1111/j.1440-1797.2008.01065.x. Nephrology (Carlton). 2009. PMID: 19207866

8

Hyperparathyroidism in chronic kidney disease: a retrospective cohort study of costs and outcomes.

Smith DH, Johnson ES, Thorp ML, Yang X, Neil N. Smith DH, et al. Among authors: johnson es. J Bone Miner Metab. 2009;27(3):287-94. doi: 10.1007/s00774-009-0048-8. Epub 2009 Mar 31. J Bone Miner Metab. 2009. PMID: 19333685

9

Comparison of renal replacement therapy and mortality using 1 versus 2 estimated glomerular filtration rates.

Thorp ML, Weinstein J, DeVille J, Johnson ES, Petrik A, Yang X, Smith DH. Thorp ML, et al. Among authors: johnson es. Popul Health Manag. 2009 Jun;12(3):149-55. doi: 10.1089/pop.2008.0024. Popul Health Manag. 2009. PMID: 19534579

10

Adherence to K/DOQI bone metabolism guidelines.

Smith DH, Johnson ES, Thorp ML, Yang X. Smith DH, et al. Among authors: johnson es. J Ren Nutr. 2009 Jul;19(4):334-42. doi: 10.1053/j.jrn.2009.01.013. J Ren Nutr. 2009. PMID: 19539186

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

374 results

Search Page

Filters